… therapy, most commonly amiodarone, … oral amiodarone but unable to take the oral preparation.
Based on the 2010 Advanced Cardiac Life Support guidelines, intravenous amiodarone …

… However, oral amiodarone is not an appropriate therapeutic option for long-term rate control.
In patients who are resistant to standard AV blocking agents such as beta-blockers, digoxin …

… seen with oral amiodarone therapy, in others, plasma amiodarone levels were unrelated to
therapeutic … Therapeutic drug monitoring can contribute to determining optimal concentration. …

… The well-described interaction between amiodarone and VKA affects the time in the
therapeutic range of VKAs by interacting with the CYP2C9 pathway; consequently, this effect is …

… who were not receiving amiodarone therapy at baseline. … for 18 h or until switched to oral
therapy (as described above) [13]… from intravenous amiodarone to oral amiodarone depends on …

… We retrospectively reviewed all patients 0-21 years of age who received oral amiodarone or
… Combination therapy of amiodarone and flecainide was not included as separate events in …

… Because ventricular arrhythmia persisted and side effects occurred to alternative therapy,
low dose of oral amiodarone was resumed and hepatotoxicity did not occur afterward. Acute …

… data supporting the use of oral amiodarone for conversion of ATA. … a single, high oral dose
of amiodarone was largely effective in … of oral amiodarone as a safe and convenient therapy. …

… The acute management of tachyarrhythmia included electrical cardioversion and intravenous
or oral anti-arrhythmic drug therapy. The long-term management of tachyarrhythmia …

… Oral Amiodarone has a slow and variable absorption rate, with … loading doses help to achieve
therapeutic levels more quickly. … are the best candidates to start oral Amiodarone therapy. …